Search
for

    Sort by

    Research 301–330 of 777

    1. Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review Dermatology and Therapy · 2025
    2. Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia) International journal of multidisciplinary research and analysis · 2023
    3. Efficacy of tofacitinib in treatment of alopecia universalis in two patients Journal of the European Academy of Dermatology and Venereology · 2016 · 51 citations
    4. Pharmacotherapy of alopecia areata Forum Dermatologicum · 2026
    5. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    6. Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study Dermatology and Therapy · 2025
    7. Recent advances in the genetics of alopecia areata Medizinische Genetik · 2023
    8. Etiopathogenesis of Alopecia Areata Hair therapy & transplantation · 2014 · 2 citations
    9. POSTĘP W DIAGNOZIE I LECZENIU STWARDNIENIA ROZSIANEGO Wiadomości Lekarskie · 2024
    10. PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ Wiadomości Lekarskie · 2024
    11. ONKOLOGIA OKULISTYCZNA WCZORAJ I DZIŚ Wiadomości Lekarskie · 2024
    12. AUTOLOGOUS FAT GRAFTING UPDATE. PRESENTATION OF OWN RESULTS IN FACIAL REGENERATION Wiadomości Lekarskie · 2024
    13. MICRO-URZĄDZENIA, BEZPRZEWODOWE KAPSUŁKI, MAPY, STYMULATORY I ROZRUSZNIKI STOSOWANE DO DIAGNOSTYKI I LECZENIA ZABURZEŃ MOTORYKI PRZEWODU POKARMOWEGO Wiadomości Lekarskie · 2024
    14. EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES Wiadomości Lekarskie · 2024
    15. THE USE OF AN IMMUNOMODULATOR WITH AN ANTISEPTIC IN THE TREATMENT OF INFECTED AND PURULENT WOUNDS IN AN EXPERIMENT Wiadomości Lekarskie · 2024
    16. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    17. INTERFERONS IN DERMATOLOGY Dermatologic Clinics · 1998 · 22 citations
    18. Poster Abstracts Fundamental & Clinical Pharmacology · 2017
    19. 808 Lichen planus single cell and spatial profiling of cutaneous lichen planus treated with baricitinib Journal of Investigative Dermatology · 2024
    20. Delayed granulomatous eruption of the nose associated with ruxolitinib JAAD case reports · 2020 · 2 citations
    21. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    22. Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal? Frontiers in Immunology · 2022
    23. Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients International Journal of Pharmaceutics · 2025
    24. Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review Journal of Neurosciences in Rural Practice · 2026
    25. Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata Dermatologic Therapy · 2025
    26. Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions MedComm · 2025 · 9 citations
    27. Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience Immunological Medicine · 2026
    28. Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib Journal of Clinical Medicine · 2025
    29. Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2024
    30. A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making Value in Health · 2025